Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Encompass Health Corporation (EHC)

NYSE: EHC · Services-Hospitals · Birmingham, AL

Our rating: Neutral

Neutral reaffirmed at $137.54, moderate conviction, November 6, 2026.

Breaks if: Two paths move the needle off Neutral. The call turns Positive if revenue growth holds above 12% for two consecutive quarterly prints while FCF yield climbs above 2.0% — together those would signal that the facility pipeline is ramping on schedule and capex intensity is normalizing. The call turns Cautious if CMS proposes an IRF payment-system rate reduction exceeding 2% for FY2027, or if reported revenue growth decelerates below 7% for two consecutive quarters, indicating the volume story is softening faster than the investment cycle assumed.

Key figures

Market value$13.1B
Revenue, last 12 months$6.3B
Net income, last 12 months$644M
Free cash flow, last 12 monthsn/a
Price to earnings20.4×
Free cash flow yieldn/a
Dividend yield0.6%
Operating marginn/a
Return on equity25.5%
Beta to the S&P 5000.34
Volatility, annualized27.5%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.6B8.9%$1.50n/a
June 30, 2026$1.6B9.6%$1.54n/a
March 31, 2026$1.6B9.0%$1.93n/a
December 31, 2025$1.5B9.9%$1.43n/a
September 30, 2025$1.5B9.4%$1.24n/a
June 30, 2025$1.5B12.0%$1.39n/a
March 31, 2025$1.5B10.6%$1.48n/a
December 31, 2024$1.4B12.7%$1.18n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

17 ledger entries and 33 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.